ESLA: ESTRELLA IMMUNOPHARMA, INC. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-08-14 | Fell below 5% | Armistice Capital, LLC | 4.99% | SEC |
Institutional ownership (Q2 2026)
15 institutions reported holding $4.99M of ESTRELLA IMMUNOPHARMA, INC. on Form 13F (16 the quarter before). 2 opened a new position and 3 sold out. Shares held by institutions: -7%.
| Largest holders | Shares | Value |
|---|---|---|
| ARMISTICE CAPITAL, LLC | 3,975,220 | $4.13M |
| VANGUARD CAPITAL MANAGEMENT LLC | 416,852 | $434K |
| GEODE CAPITAL MANAGEMENT, LLC | 141,321 | $147K |
| VANGUARD FIDUCIARY TRUST CO | 64,921 | $68K |
| BlackRock, Inc. | 52,033 | $54K |
| STATE STREET CORP | 43,252 | $45K |
| RENAISSANCE TECHNOLOGIES LLC | 39,100 | $41K |
| NORTHERN TRUST CORP | 34,861 | $36K |
| US BANCORP \DE\ | 20,000 | $21K |
| Tower Research Capital LLC (TRC) | 3,308 | $3K |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.